JASPER THERAPEUTICS INC (JSPR) Stock Income Statement
USA - NASDAQ:JSPR - US4718712023 - Common Stock
2.3987 USD
+0.07 (+2.95%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 94.05M | 76.24M | 68.86M | 51.20M | 36.83M | |||
| Research and Development | 71.58M | 55.82M | 51.78M | 34.63M | 25.42M | |||
| Selling, General, and Administrative Expenses | 22.47M | 20.42M | 17.08M | 16.57M | 11.41M | |||
| Operating Income | -94.05M | -76.24M | -68.86M | -51.20M | -36.83M | |||
| Interest Income/Expense | 3.28M | 5.06M | 5.20M | 0.00 | -3.50M | |||
| Other Income/Expense | -153.00K | -88.00K | -803.00K | 13.51M | 9.70M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -90.92M | -71.27M | -64.47M | -37.69M | -30.64M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -90.92M | -71.27M | -64.47M | -37.69M | -30.64M | |||
| EBITDA | -92.73M | -74.87M | -67.75M | -50.22M | -36.46M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -6.02 | -4.89 | -6.18 | -10.33 | -8.09 | |||
| Non GAAP EPS | -6.01 | -4.86 | -6.20 | -10.30 | N/A | |||
| Statistics | ||||||||
All data in USD